Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: neurodegenerative diseases

MIT study reveals how specific cells in AD become vulnerable and resilient

MIT study reveals how specific cells in AD become vulnerable and resilient
p p Read More

The neurodegenerative condition is recognised as the most common form of dementia

July 29, 2024 Alzheimer's disease, Dementia, Massachusetts Institute of Technology, neurodegenerative diseases, News, reelin, Religious Order Study, Rush Memory and Aging Project

KCL study finds cell ageing could reveal early signs of neurodegenerative disease

KCL study finds cell ageing could reveal early signs of neurodegenerative disease
p p Read More

Conditions such as Alzheimer’s and Parkinson’s affect over one million people in the UK

July 25, 2024 ageing cells, King’s College London, neurodegenerative diseases, neurons, News, Uncategorized

MJFF awards $6m to Lario Therapeutics for Parkinson’s research

MJFF awards m to Lario Therapeutics for Parkinson’s research
p p Read More

The neurological disease is estimated to affect more than ten million people globally

July 23, 2024 CaV2.3 calcium channel inhibition, Michael J. Fox Foundation, neurodegenerative diseases, neurological conditions, News, Parkinson's disease

Researchers awarded £1.5m for national dementia inequalities network

Researchers awarded £1.5m for national dementia inequalities network
p p Read More

The ESRC EquaDem Network Plus aims to improve disparities in diagnosis and care

July 11, 2024 ESRC Equalities in Dementia Network Plus, national network for dementia, neurodegenerative diseases, News, University of Liverpool

Mission awarded $5.2m to advance potential Parkinson’s treatment

Mission awarded .2m to advance potential Parkinson’s treatment
p p Read More

The progressive neurodegenerative condition affects around 153,000 people in the UK

July 8, 2024 Michael J. Fox Foundation, Mission Therapeutics, MTX325, neurodegenerative diseases, News, Parkinson's disease, Parkinson’s UK

Parkinson’s UK awards ICL £100,000 to develop small drugs for Parkinson’s disease

Parkinson’s UK awards ICL £100,000 to develop small drugs for Parkinson’s disease
p p Read More

The neurodegenerative condition currently affects around 153,000 people in the UK

June 28, 2024 brain simulation, GPNMB, Imperial College London, neurodegenerative diseases, News, Parkinson's disease, Parkinson’s UK

UK dementia organisations publish new manifesto ahead of general election

UK dementia organisations publish new manifesto ahead of general election
p p Read More

The manifesto calls on the next UK government to make dementia a key health priority

June 24, 2024 Alzheimer Scotland, Alzheimer's Research UK, Alzheimer’s Society, Dementia, Dementia UK, Dementia: a manifesto, neurodegenerative diseases, News, UK Dementia Research Institute

Researchers suggest form of Alzheimer’s is transmissible via bone marrow transplants

The progressive neurodegenerative disease is estimated to affect 24 million people globally

April 3, 2024 Alzheimer's disease, amyloid, amyloid precursor protein, bone marrow transplants, Dementia, neurodegenerative diseases, News, University of British Columbia

Skin biopsy test detects abnormalities of key biomarker in neurodegenerative disorders

Estimated to affect 2.5 million people in the US, synucleinopathies comprise four neurodegenerative disorders

March 25, 2024 alpha-synuclein, Beth Israel Deaconess Medical Center, neurodegenerative diseases, News, skin biopsy, synucleinopathies
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy